amobarbital has been researched along with Briquet Syndrome in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wijdicks, EFM | 1 |
| Mai, FM | 1 |
2 other studies available for amobarbital and Briquet Syndrome
| Article | Year |
|---|---|
Functional neurology after the Second World War: The beginnings of neurology on screen (III).
Topics: Adult; Amobarbital; Combat Disorders; Diagnosis, Differential; Follow-Up Studies; History, 20th Cent | 2020 |
Briquet's syndrome (hysteria) and the physician.
Topics: Amobarbital; Female; Humans; Hysteria; Male; Psychotherapy; Somatoform Disorders | 1982 |